SCHEMBL1268893

SCHEMBL1268893

C=CCC1=N[CH]CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11668197 0.68
SCHEMBL225335 0.62
SCHEMBL1268892 0.62
SCHEMBL4932232 0.61 KDM4E (0.36)
SCHEMBL2017885 0.61
SCHEMBL8860815 0.60
SCHEMBL1083170 0.58
Methyl Alcohol SCHEMBL11203341 0.58
SCHEMBL6689397 0.58
SCHEMBL7857170 0.57 NOS3 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102690229-A Brand new synthesis of Montelukast Sodium and its preparation intermediates SHANGHAI XIANGHUI MEDICAL TECHNOLOGY CO LTD 2012-09-26 CN claimed
CN-118105513-A Conjugates comprising self-degrading groups and methods related thereto 乐高化学生物科学股份有限公司 2024-05-31 CN disclosed
US-11975076-B2 Antibody-drug conjugates comprising branched linkers and methods related thereto LEGOCHEM BIOSCIENCES, INC. (KR) 2024-05-07 US disclosed
EP-3380124-B1 CONJUGATES COMPRISING SELF-IMMOLATIVE GROUPS AND METHODS RELATED THERETO LEGOCHEM BIOSCIENCES INC (KR) 2024-04-03 EP disclosed
CN-117244076-A Conjugates comprising self-degrading groups and methods related thereto 乐高化学生物科学股份有限公司 2023-12-19 CN disclosed
US-20220226496-A1 LIGAND-DRUG CONJUGATE INCLUDING LINKER HAVING TRIS STRUCTURE LEGOCHEM BIOSCIENCES, INC. (KR) 2022-07-21 US disclosed
US-20220218840-A1 ANTIBODY-DRUG CONJUGATES COMPRISING BRANCHED LINKERS AND METHODS RELATED THERETO LIGACHEM BIOSCIENCES INC. (KR) 2022-07-14 US disclosed
EP-3964236-A1 LIGAND-DRUG CONJUGATE INCLUDING LINKER HAVING TRIS STRUCTURE LegoChem Biosciences, Inc. (KR) 2022-03-09 EP disclosed
CN-107847605-B Antibody-drug conjugates comprising branched linkers and methods related thereto 乐高化学生物科学股份有限公司 2021-12-24 CN disclosed
CN-113727734-A Ligand-drug conjugates comprising a linker having a tris structure 乐高化学生物科学股份有限公司 2021-11-30 CN disclosed
US-20040010154-A1 Diastereoselective hydrogenation of 1,3-hydroxyketones SOLVIAS AG (CH) 2004-01-15 US disclosed
EP-1378500-A1 Diastereoselective hydrogenation of beta-hydroxy ketones Solvias AG (CH) 2004-01-07 EP disclosed
EP-1378501-A1 Diastereoselective hydrogenation of beta-hydroxyketones Solvias AG (CH) 2004-01-07 EP disclosed
WO-2003044011-A1 PYRROLE SYNTHESIS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-05-30 WO disclosed
WO-2003004450-A1 PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF STATIN DERIVATIVES ESPECIALLY 7-AMINO 3,5-DIHYDROXY HEPTANOIC ACID DERIVATIVES, AND INTERMEDIATES THEREOF CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-01-16 WO disclosed
WO-2003004456-A1 PROCESS FOR THE PREPARATION OF 7-AMINO SYN 3,5-DIHYDROXY HEPTANOIC ACID DERIVATIVES VIA 6-CYANO SYN 3,5-DIHYDROXY HEXANOIC ACID DERIVATIVES TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2003-01-16 WO disclosed
WO-2003004455-A2 PROCESS FOR THE PREPARATION OF 7-AMINO SYN 3,5-DIHYDROXY HEPTANOIC ACID DERIVATIVES, INTERMEDIATES THEREOF AND METHODS FOR THEIR PREPARATION TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2003-01-16 WO disclosed
US-6358665-B1 ONIUM SALT PRECURSOR FOR GENERATING FLUOROALKYLSULFONATE CLARIANT INTERNATIONAL LTD. (CH) 2002-03-19 US disclosed
CN-1274433-A Radiation-sensitive compsn. of chemical amplification type containing onium salt type photosensitive acid generating agent CLARIANT INT LTD (CH) 2000-11-22 CN disclosed
EP-1033624-A1 RADIATION-SENSITIVE COMPOSITION OF CHEMICAL AMPLIFICATION TYPE Clariant International Ltd. (CH) 2000-09-06 EP disclosed